| Dr Pamela Lynn Ralls, MD | |
|
1502 N.jefferson Street, Ccmh Medical Plaza, Carrollton, MO 64633 | |
| (660) 542-1695 | |
| (660) 542-9880 |
| Full Name | Dr Pamela Lynn Ralls |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 16 Years |
| Location | 1502 N.jefferson Street, Carrollton, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023252541 | NPI | - | NPPES |
| 204313506 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 2008018043 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Carroll Co Mem Hospital Home Health Care Agency | Carrollton, MO | Home health agency |
| Shirkey Hospice And Palliative Care | Richmond, MO | Hospice |
| Carroll County Memorial Hospital | Carrollton, MO | Hospital |
| Hedrick Medical Center | Chillicothe, MO | Hospital |
| Life Care Center Of Carrollton | Carrollton, MO | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Carroll County Memorial Hospital | 2860485638 | 55 |
| Jefferson Medical Group | 6800894379 | 9 |
News Archive
Researchers at Massachusetts General Hospital (MGH) have developed a deep learning model that identifies imaging biomarkers on screening mammograms to predict a patient's risk for developing breast cancer with greater accuracy than traditional risk assessment tools.
Researchers from the John Theurer Cancer Center at Hackensack University Medical Center played an important role in a study that led to the Food & Drug Administration's (FDA) recent fast tracking of ipilimumab, a promising treatment for metastatic melanoma. The FDA based its decision largely on the results of a pivotal study published in the New England Journal of Medicine on August 19, 2010 – the same day the agency accepted Bristol-Myers Squibb's application for the drug's approval and granted the application priority review status.
It turns out that, when someone is spending his own money alone for routine expenses, he is far more likely to ask the questions he would ask if purchasing any other good or service: "Is there a generic version of that drug?" (Gov. Mitch Daniels, 3/1).
Researchers used 3D imaging with molecular testing to uncover new insight into the earliest stages of mammalian pregnancy-offering clues to unsolved questions in pregnancy.
› Verified 8 days ago
| Entity Name | Carroll County Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528067113 PECOS PAC ID: 2860485638 Enrollment ID: O20040407000120 |
News Archive
Researchers at Massachusetts General Hospital (MGH) have developed a deep learning model that identifies imaging biomarkers on screening mammograms to predict a patient's risk for developing breast cancer with greater accuracy than traditional risk assessment tools.
Researchers from the John Theurer Cancer Center at Hackensack University Medical Center played an important role in a study that led to the Food & Drug Administration's (FDA) recent fast tracking of ipilimumab, a promising treatment for metastatic melanoma. The FDA based its decision largely on the results of a pivotal study published in the New England Journal of Medicine on August 19, 2010 – the same day the agency accepted Bristol-Myers Squibb's application for the drug's approval and granted the application priority review status.
It turns out that, when someone is spending his own money alone for routine expenses, he is far more likely to ask the questions he would ask if purchasing any other good or service: "Is there a generic version of that drug?" (Gov. Mitch Daniels, 3/1).
Researchers used 3D imaging with molecular testing to uncover new insight into the earliest stages of mammalian pregnancy-offering clues to unsolved questions in pregnancy.
› Verified 8 days ago
| Entity Name | Jefferson Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215030713 PECOS PAC ID: 6800894379 Enrollment ID: O20061116000198 |
News Archive
Researchers at Massachusetts General Hospital (MGH) have developed a deep learning model that identifies imaging biomarkers on screening mammograms to predict a patient's risk for developing breast cancer with greater accuracy than traditional risk assessment tools.
Researchers from the John Theurer Cancer Center at Hackensack University Medical Center played an important role in a study that led to the Food & Drug Administration's (FDA) recent fast tracking of ipilimumab, a promising treatment for metastatic melanoma. The FDA based its decision largely on the results of a pivotal study published in the New England Journal of Medicine on August 19, 2010 – the same day the agency accepted Bristol-Myers Squibb's application for the drug's approval and granted the application priority review status.
It turns out that, when someone is spending his own money alone for routine expenses, he is far more likely to ask the questions he would ask if purchasing any other good or service: "Is there a generic version of that drug?" (Gov. Mitch Daniels, 3/1).
Researchers used 3D imaging with molecular testing to uncover new insight into the earliest stages of mammalian pregnancy-offering clues to unsolved questions in pregnancy.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Pamela Lynn Ralls, MD 1502 N Jefferson St, Ccmh Medical Plaza Attn: Jean Steele, Carrollton, MO 64633 Ph: (660) 542-1695 | Dr Pamela Lynn Ralls, MD 1502 N.jefferson Street, Ccmh Medical Plaza, Carrollton, MO 64633 Ph: (660) 542-1695 |
News Archive
Researchers at Massachusetts General Hospital (MGH) have developed a deep learning model that identifies imaging biomarkers on screening mammograms to predict a patient's risk for developing breast cancer with greater accuracy than traditional risk assessment tools.
Researchers from the John Theurer Cancer Center at Hackensack University Medical Center played an important role in a study that led to the Food & Drug Administration's (FDA) recent fast tracking of ipilimumab, a promising treatment for metastatic melanoma. The FDA based its decision largely on the results of a pivotal study published in the New England Journal of Medicine on August 19, 2010 – the same day the agency accepted Bristol-Myers Squibb's application for the drug's approval and granted the application priority review status.
It turns out that, when someone is spending his own money alone for routine expenses, he is far more likely to ask the questions he would ask if purchasing any other good or service: "Is there a generic version of that drug?" (Gov. Mitch Daniels, 3/1).
Researchers used 3D imaging with molecular testing to uncover new insight into the earliest stages of mammalian pregnancy-offering clues to unsolved questions in pregnancy.
› Verified 8 days ago
Dr. Marvin E Ross, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1502 N Jefferson St, Jefferson Medical Group /attn: Jean Steele, Carrollton, MO 64633 Phone: 660-542-9998 Fax: 660-542-9880 | |
Andrew Douglas Horine, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1502 N Jefferson St, Carrollton, MO 64633 Phone: 660-542-1695 Fax: 660-542-3902 | |
Timothy Neil Reid, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1502 N Jefferson St, Carrollton, MO 64633 Phone: 660-542-1695 Fax: 660-542-1944 | |
Richard Lee Smith, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1502 N Jefferson St, Carrollton, MO 64633 Phone: 660-542-9998 Fax: 660-542-9880 | |
Dr. Donald Leroy Kampschmidt, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 204 Johnson Cir, Carrollton, MO 64633 Phone: 660-542-3418 |